论文信息 - Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial) - 字舞流文

Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial)

K. Döhner | R. Schlenk | H. Döhner | V. Gaidzik | P. Paschka | M. Heuser | F. Thol | A. Ganser | K. Götze | M. Lübbert | W. Fiedler | M. Kebenko | P. Reimer | M. Verbeek | J. Krauter | H. Becker | M. Wattad | B. Neuhaus | M. Janning | C. Greil | C. Könecke | A. Papkalla